Ad blocker interference detected!
Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers
Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
|Niemann–Pick disease, SMPD1-associated|
|Classification and external resources|
|ICD-10||E752 (ILDS E75.230)|
There are approximately 1,200 cases of NPA and NPB worldwide with the majority of cases being Type B or an intermediate form.
Niemann–Pick Type A, the most common type, occurs in infants and is characterized by jaundice, an enlarged liver, failure to thrive, progressive deterioration of the nervous system and profound brain damage. Children affected by Niemann Pick Type A rarely live beyond 18 months. Niemann–Pick Type A occurs more frequently among individuals of Ashkenazi (eastern and central European) Jewish descent than in other ethnicities. The incidence within the Ashkenazi population is approximately 1 in 40,000 people. The incidence for other populations is 1 in 250,000 people.
Niemann–Pick Type B involves an enlarged liver and spleen hepatosplenomegaly, growth retardation, and problems with lung function including frequent lung infections. Other signs include blood abnormalities such as abnormal cholesterol and lipid levels, and low numbers of blood cells involved in clotting (platelets). The brain is not affected in Type B and the disease often presents in the pre-teen years.
Mutations in the SMPD1 gene cause Niemann–Pick Types A and B. This gene carries instructions for cells to produce an enzyme called acid sphingomyelinase. Insufficient activity of the enzyme acid sphingomyelinase causes the build up of toxic amounts of sphingomyelin, a fatty substance present in every cell of the body. This enzyme is found in special compartments within cells called lysosomes (compartments that digest and recycle materials in the cell), and is required to metabolize the lipid sphingomyelin. If sphingomyelinase is absent or not functioning properly, sphingomyelin cannot be metabolized properly and is accumulated within the cell, eventually causing cell death and the malfunction of major organ systems.
- ↑ LYNN R, TERRY RD (December 1964). LIPID HISTOCHEMISTRY AND ELECTRON MICROSCOPY IN ADULT NIEMANN–PICK DISEASE. The American Journal of Medicine 37 (6): 987–94.
- ↑ Schneider EL, Pentchev PG, Hibbert SR, Sawitsky A, Brady RO (October 1978). A new form of Niemann–Pick disease characterised by temperature-labile sphingomyelinase. Journal of medical genetics 15 (5): 370–4.
- ↑ OMIM – NIEMANN–PICK DISEASE, TYPE B. URL accessed on 2008-10-27.
- GeneReviews/NCBI/NIH/UW entry on Acid Sphingomyelinase Deficiency Includes: Niemann–Pick Disease Type A, Niemann–Pick Disease Type B
- OMIM entries on Acid Sphingomyelinase Deficiency
- Hide & Seek Foundation for Lysosomal Disease Research
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|